{"id":"W1594902063","doi":"10.1007/s00280-002-0566-8","title":"Phase I and pharmacokinetic study of anhydrovinblastine every 3 weeks in patients with refractory solid tumors","year":2003,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Discovery Air (Canada)","funders":"National Cancer Institute","keywords":"Pharmacokinetics; Refractory (planetary science); Medicine; Solid tumor; Maximum tolerated dose; Internal medicine; Oncology; Pharmacology; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006526996,0.0002103666,0.0006903749,0.00008945717,0.00003640992,0.000005813535,0.00009010993,0.0000811807,0.0009495919],"category_scores_gemma":[0.0005203472,0.0001685393,0.00002184845,0.0001784402,0.0002256454,0.00005046762,0.00002267584,0.0002678882,3.339347e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003504151,"about_ca_system_score_gemma":0.00005480514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001198529,"about_ca_topic_score_gemma":0.000006024393,"domain_scores_codex":[0.9980295,0.0006034466,0.0005946413,0.0003632787,0.0001575745,0.0002516142],"domain_scores_gemma":[0.9955466,0.003846691,0.000281981,0.0001263487,0.00007739487,0.0001210031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04677998,0.08101133,0.4288191,0.00255191,0.002919612,0.0001608068,0.01102664,0.00008480944,0.09619059,0.001258312,0.006284185,0.3229127],"study_design_scores_gemma":[0.5611614,0.04839141,0.07658257,0.0005919248,0.001999214,0.0000162004,0.001078051,0.001110568,0.2252522,0.0754693,0.005862656,0.002484482],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980292,0.0002145266,0.0003214279,0.00005205526,0.0002731475,0.000896668,0.00003882109,0.00001716158,0.0001569481],"genre_scores_gemma":[0.9925454,0.0002733905,0.00644717,0.0004868675,0.00007926589,0.00009265683,6.241318e-7,0.00003393119,0.00004066233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5143814,"threshold_uncertainty_score":0.9999637,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1627209557731493,"score_gpt":0.5160638178940202,"score_spread":0.353342862120871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}